# Erythropoietin for Management of Anemia Caused by Chemotherapy

Source: https://onco.cc/trials/nct02890602/  
OnCo record `nct02890602` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Darbepoetin alfa, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone in Diffuse large B-cell lymphoma, run by Kosin University Gospel Hospital, completed.

## Summary

Erythropoietin for Management of Anemia Caused by Chemotherapy is a phase 2 interventional study registered as NCT02890602 by Kosin University Gospel Hospital, with 53 participants recorded, started 2012-09-01 and reaching its primary completion in 2017-11-28. Interventions recorded: Darbepoetin alfa, R-CHOP. Conditions recorded: Diffuse Large B-cell Lymphoma.

Linked to the drug Darbepoetin alfa because the registry names it among its interventions and Diffuse large B-cell lymphoma among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT02890602
- Phase: 2
- Setting: A Phase Ⅱ Study of Erythropoietin for Management of Anemia Caused by Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
- Sponsor: Kosin University Gospel Hospital
- Enrolled: 53

## Sources

- ClinicalTrials.gov NCT02890602: https://clinicaltrials.gov/study/NCT02890602

## Connected records

- cancers: [Diffuse large B-cell lymphoma](https://onco.cc/cancers/dlbcl/)
- drugs: [Cyclophosphamide](https://onco.cc/drugs/cyclophosphamide/), [Darbepoetin alfa](https://onco.cc/drugs/darbepoetin-alfa/), [Doxorubicin](https://onco.cc/drugs/doxorubicin/), [Prednisone](https://onco.cc/drugs/prednisone/), [Rituximab](https://onco.cc/drugs/rituximab/), [Vincristine](https://onco.cc/drugs/vincristine/)

---
JSON: https://onco.cc/api/v1/entities/nct02890602.json